Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Roel F. Maas-Bakker
Quality Comparison of Biosimilar and Copy Filgrastim Products With the Innovator Product
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Related publications
Comparison of the Pharmacodynamic Profiles of a Biosimilar Filgrastim and Amgen Filgrastim: Results From a Randomized, Phase I Trial
Annals of Hematology
Medicine
Hematology
Pharmacokinetic Profiles of a Biosimilar Filgrastim and Amgen Filgrastim: Results From a Randomized, Phase I Trial
Annals of Hematology
Medicine
Hematology
Regulatory and Clinical Experiences With Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada
Oncologist
Cancer Research
Medicine
Oncology
Filgrastim-SNDZ Debuts as the First Biosimilar Approved in United States
Journal of Community and Supportive Oncology
Oncology
Hematology
Expanded Access to Cancer Treatments From Conversion to Neutropenia Prophylaxis With Biosimilar Filgrastim-SNDZ
Future Oncology
Medicine
Cancer Research
Oncology
Pcn32 - The Effectiveness and Safety of Switching From Orginal Filgrastim to Biosimilar Filgrastim in Primary Prophylaxis of Chemotherapy Induced Febrile Neutropenia: A Retrospective Cohort Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparative Studies of Biosimilar Medicinal Products
The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products
Cross-National Comparison of Biosimilar Medicines : Market Penetration and Competition With Originators
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Letter: Is There a Role for Infliximab Biosimilar in Patients With Inflammatory Bowel Disease With Secondary Loss of Response to Infliximab Innovator?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
